Navigation Links
Isis Pharmaceuticals Announces the Initiation of a Clinical Study of ISIS-STAT3 Rx in Patients with Liver Cancer
Date:5/6/2013

wo of three patients with advanced diffuse large B cell lymphoma who were refractory to multiple prior chemotherapy treatments.  Isis and AstraZeneca are currently evaluating ISIS-STAT3Rx in two Phase 1b/2a clinical studies in patients with HCC and advanced lymphomas.  Because STAT3 is over expressed in numerous types of cancers, ISIS-STAT3Rx has the potential to be broadly useful for both solid and hematological tumors. 

ABOUT ISIS PHARMACEUTICALS, INC.
Isis is exploiting its leadership position in antisense technology to discover and develop novel drugs for its product pipeline and for its partners.  Isis' broad pipeline consists of 28 drugs to treat a wide variety of diseases with an emphasis on cardiovascular, metabolic, severe and rare diseases, and cancer.  Isis' partner, Genzyme, is commercializing Isis' lead product, KYNAMRO™, in the United States for the treatment of patients with HoFH.  Genzyme is also pursuing marketing approval of KYNAMRO in other markets.  Isis' patents provide strong and extensive protection for its drugs and technology.  Additional information about Isis is available at www.isispharm.com.

ISIS PHARMACEUTICALS' FORWARD-LOOKING STATEMENT
This press release includes forward-looking statements regarding Isis' strategic alliance with AstraZeneca, the development, activity, therapeutic potential and safety of ISIS-STAT3Rx, and the therapeutic benefit of antisense drugs that incorporate Isis' Generation 2.5 chemistry. Any statement describing Isis' goals, expectations, financial or other projections, intentions or beliefs, including the commercial potential of KYNAMRO, is a forward-looking statement and should be considered an at-risk statement.  Such statements are subject to certain risks and uncertainties, particularly those inherent in the process of discovering, dev
'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Savient Pharmaceuticals to Hold First Quarter 2012 Financial Results Conference Call on Wednesday, May 9, 2012
2. Auxilium Pharmaceuticals to Present at the Deutsche Bank 37th Annual Healthcare Conference
3. Nouveau Life Pharmaceuticals (HRID) Contracts with U.S. Manufacturer to Produce New Female Supplement
4. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
5. Icahn Issues Statement Regarding Amylin Pharmaceuticals
6. Almost 50 Percent of the Glaucoma Patient Population Remains Untreated, Signifying a Vast Market for Glaucoma Pharmaceuticals, Finds Frost & Sullivan
7. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
8. Onyx Pharmaceuticals Announces FDA Advisory Committee to Review Carfilzomib for the Treatment of Patients with Relapsed and Refractory Multiple Myeloma
9. Jazz Pharmaceuticals Announces First Quarter 2012 Financial Results Conference Call On May 8, 2012
10. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
11. Avanir Pharmaceuticals To Present at Three Conferences In May
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... --  Millar, Inc. , a leader in catheter-based and ... of Craig Thummel , President/CEO and member of ... to the Company. The Company also announced its leadership ... Executive Management team as his successors. The Board of ... of Sales and Marketing, as President, and also a ...
(Date:6/30/2015)... VALLEY, Pa. , June 30, 2015 /PRNewswire/ ... and delivering innovative solutions for medical and surgical ... is guaranteeing next-day replacements for surgical equipment at ... product manufacturer to offer this type of guarantee. ... Olympus Full Service Agreement earlier this year. ...
(Date:6/30/2015)... FREMONT, Calif. , June 30, 2015  Ardelyx, ... focused on cardio-renal, gastrointestinal and metabolic diseases, today announced ... on July 14, 2015, from 8:00 a.m.- 1:00 pm ... The Ardelyx senior management team will ... its lead compound, tenapanor, which has completed Phase 2b ...
Breaking Medicine Technology:Millar, Inc. Announces Leadership Changes 2Millar, Inc. Announces Leadership Changes 3Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 2Olympus Introduces Industry-First Next-Day Product Replacement Guarantee for Surgical Business 3Ardelyx to Host Inaugural R&D Investor Day in New York City on July 14, 2015 2
... SAN DIEGO, Oct. 7 CareFusion Corporation (NYSE: CFN ) ... 2010 on Tuesday, Nov. 10 following the close of trading on ... webcast and conference call on Nov. 10 at 2:00 pm Pacific ... first quarter, ended on Sep. 30, 2009. To access the call ...
... October 7 DBMS Consulting announced that it,has successfully ... Oracle E-Business Suite (EBS) for SIRO Clinpharm, one of ... fully,automated capabilities in management of clinical trial process, clinical,trial ... After this implementation, SIRO gains complete operational ...
Cached Medicine Technology:CareFusion Will Host An Earnings Conference Call on November 10, 2009 to Discuss the Results for the First Quarter of Fiscal 2010 2DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm 2DBMS Consulting Successfully Completes Roll out of Oracle Health Sciences Applications (OHSA) Suite for SIRO Clinpharm 3
(Date:6/30/2015)... ... June 30, 2015 , ... Lakeview Health, a drug ... the size of its medical staff to further enhance its ability to treat ... nurse practitioners and physician assistants -- now totals 17, compared to 7 in ...
(Date:6/30/2015)... ... June 30, 2015 , ... The progress of ... multidistrict litigation now underway in the U.S. District Court, Eastern District of Louisiana, ... to the Court’s calendar, that conference has now been scheduled for July 9th, ...
(Date:6/30/2015)... ... June 30, 2015 , ... Dr. Sammy Masri of Masri ... physician. He specializes in the diagnosis and treatment of non-surgical sports and other musculoskeletal ... who participate in recreational athletics and use exercise to stay healthy and active. Dr. ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... general manager of HRA Healthcare Research & Analytics , a consultative healthcare ... Associates, Inc. (MJH) family of businesses. HRA offers quantitative and qualitative, custom and ...
(Date:6/30/2015)... ... June 30, 2015 , ... ... partnering to improve access to cancer prevention, screening and care for the people ... announced an affiliation that will see Roswell Park faculty providing clinical consultations to ...
Breaking Medicine News(10 mins):Health News:Lakeview Health, a Nationally Recognized Drug Rehabilitation Center in Florida, Doubles Size of Medical Staff 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 2Health News:Progress of Federal Xarelto Lawsuits Pending in Multidistrict Litigation to Be Discussed During July 9th Status Conference 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 2Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 3Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 4Health News:NJ Top Docs Presents Dr. Sammy Masri; Dr. Masri is Now Offering a Wide Range of Services to his Valued Patients 5Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 2Health News:HRA Healthcare Research & Analytics Welcomes 'Creative Problem Solver' as New Executive Vice President 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 2Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 3Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 4Health News:Intercontinental Oncology Partnership Brings Access to Specialized Cancer Care to Nigeria 5
... the late 1950s was later discarded as a stunt. However ... is the one who pioneered this in 1957. He claimed ... than a second actually bought the advertised product. He had ... see his results in the tests they had conducted. Vicary ...
... 700 neighbourhoods across India will be imparted vocational training ... therapy came to India in 1984, around 11 million ... are still not leading a life of dignity," Nippon ... ,"We have decided to give them location specific vocational ...
... in UK by scientists from the Imperial College London have found ... in the human body//, leads to a reduced appetite and higher ... ,They explained that the hormone, oxyntomodulin, is what tells our brains ... who struggle with obesity have less of this hormone than those ...
... Newcastle-upon-Tyne, there is an acute failure to deal with the ... the UK//. Patients with such diseases are able to get ... says that sexually transmitted infections (STIs) have increased by 10 ... average of 2 percent. The number of patients with syphilis ...
... contest, which offers a handsome prize money of $10,000, has ... with it finding its phone lines jammed on the very ... Sciences (AIMS) here is a partner of Fnland's National Institute ... over. ,"This contest is open to all ...
... with spinal-cord injuries has allowed them to walk again ... promise for people with traumatic spinal-cord injuries. ... of neurosurgery at Baylor College of Medicine in Houston ... called astrocytes and this resulted in a 40-percent rise ...
Cached Medicine News:Health News:A New Study Shows That A Hormone Could Lead To Weight Loss 2Health News:Stem Cell Technology Gives Hope in Spinal Cord Injuries 2
Six inch wide elastic belt transfers the apron weight off the shoulders. 0.5mm front and 0.25mm back with a generous overlap for double protection. Shoulder pads included. Also available without wide...
Front protection with choice of adjustable 2" buckle or velcro belt which crosses the back for a comfortable fit. Adjustable straps at shoulders keeps apron snug....
... Versatile, pocket-size peripheral ... either a full-function nerve ... block monitor, depending upon ... is attached. Includes NSL-5 ...
Low pressure automatic tourniquet with manual time. Includes extension hose and spiral replacement hose....
Medicine Products: